Apricus Biosciences Revenue, Profits - APRI Annual Income Statement

Add to My Stocks
$0.28 $0 (0%) APRI stock closing price Sep 19, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Apricus Biosciences stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from 5.76M to - and how operating and non operating activities have impacted the APRI stock. Along with Apricus Biosciences assets and Apricus Biosciences free cash flow, Apricus Biosciences profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $- and the 2017 revenue is $-.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Apricus Biosciences Revenues or Net Sales
-5.76M4.83M9.25M2.51M8.41M4.1M4.97M2.97M5.95M
Cost Of Goods Sold (COGS)-3.89M--2.63M4.55M2.23M3.94M--
Apricus Biosciences Gross Profit
-1.87M3.91M8.34M-0.12M3.86M1.86M1.03M2.84M5.95M
Research & Development Expense3.46M6.83M14.64M21.28M5.12M5.37M5.82M2.11M1.88M5.41M
Selling General & Admin Expense7.21M8.44M10.61M9.61M12.12M15.12M11.46M10.15M4.19M5.72M
Income Before Depreciation Depletion Amortization-10.67M-13.4M-21.35M-22.55M-17.36M-16.64M-15.42M-11.23M-3.23M-5.17M
Depreciation Depletion Amortization-----8.25M----
Non Operating Income-0.99M6.99M3.17M-2.22M--2.32M-9.42M-0.55M-
Interest Expense-1.02M-----8.85M28.69M1M
Apricus Biosciences Pretax Income
-11.74M-7.43M-19.02M-22.47M-15.87M-25.04M-18.11M-29.5M-32.48M-6.1M
Provision for Income Taxes---------0.43M-0.93M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-11.74M-7.43M-19.02M-22.47M-15.87M-25.56M-18.11M-29.5M-32.04M-5.17M
Extraordinary Items & Discontinued Operations12.07M----1.06M-6.21M----
Apricus Biosciences Profit/ Loss (Net Income)
--7.43M-19.02M-21.78M-16.93M-31.77M-18.11M-29.5M-32.04M-5.17M
Average Shares used to compute Diluted EPS11.89M6.52M5.01M3.96M3.44M2.75M2M1.18M8.86M-
Average Shares used to compute Basic EPS11.89M6.52M5.01M3.96M3.44M2.75M2M1.18M8.86M-
Income Before Nonrecurring Items-11.75M-7.43M-19.02M-8.88M-15.87M-16.01M-15.36M-19.34M-31.46M-5.17M
Income from Nonrecurring Items----13.6M--9.55M-2.76M-10.17M-0.59M-
Apricus Biosciences Earnings Per Share Basic Net
0.02-1.14-3.80-5.50-4.90-11.60-9.00-24.90-3.60-9.00
Apricus Biosciences Earnings Per Share Diluted Net
0.02-1.14-3.80-5.50-4.90-11.60-9.00-24.90-3.60-9.00
EPS Diluted Before Nonrecurring Items-0.99-1.14-3.80-2.30-4.60-5.80-7.60-16.30-3.50-9.00
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Apricus Biosciences stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2017. Our Apricus Biosciences revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like Apricus Biosciences try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The APRI financials along with Apricus Biosciences historical stock prices provide a lot of details about the firm.

Apricus Biosciences Income Statement - Key Financial Ratios

Operating Margin
0
Net Profit Margin
0